AbbVie Inc. (ABBV) vs QUALCOMM Incorporated (QCOM)
A side-by-side comparison of AbbVie Inc. and QUALCOMM Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; QCOM is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
QCOM
QUALCOMM Incorporated
$181.97TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABBV vs QCOM
growth of $100 · dividends reinvested · last 10yABBV +497.3% (+19.6%/yr)QCOM +266.0% (+13.9%/yr)ABBV compounded faster over this window
ABBV QCOM
ABBV vs QCOM: by the numbers
- •ABBV is the larger company ($454.17B vs $191.07B market cap).
- •QCOM trades at the lower trailing earnings multiple (20.77 vs 72.43 P/E), one valuation lens rather than an overall verdict.
- •QCOM converts more revenue to profit (21.01% vs 9.81% net margin).
- •QCOM grew revenue faster over the past five years (6.23% vs 3.69% CAGR).
- •ABBV pays the higher dividend yield (2.68% vs 2.05%).
Metrics side by side
Valuation
| Metric | ABBV | QCOM |
|---|---|---|
| P/E ratio | 72.43 | 20.77 |
| Forward P/E | 18.32 | 17.26 |
| P/S ratio | 7.05 | 4.34 |
| P/B ratio | N/A | 6.91 |
| EV / EBITDA | 19.34 | 17.11 |
| FCF yield | 3.99% | 5.45% |
Profitability
| Metric | ABBV | QCOM |
|---|---|---|
| Gross margin | 71.48% | 54.23% |
| Operating margin | 29.32% | 23.19% |
| Net margin | 9.81% | 21.01% |
| ROE | N/A | 33.48% |
| ROIC | 13.46% | 17.42% |
Dividends
| Metric | ABBV | QCOM |
|---|---|---|
| Dividend yield | 2.68% | 2.05% |
| Payout ratio | 192.43% | 41.32% |
Growth (annualized)
| Metric | ABBV | QCOM |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 6.23% |
| EPS CAGR (5Y) | -2.79% | 2.02% |
| FCF CAGR (5Y) | 0.11% | 2.09% |
| Total return CAGR (5Y) | 23.51% | 6.80% |
Frequently asked
- Which has the lower trailing P/E, ABBV or QCOM?
- QCOM has the lower trailing P/E: ABBV trades at 72.43 and QCOM at 20.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or QCOM?
- Over the past five years, QCOM grew revenue faster — ABBV at a 3.69% CAGR versus QCOM at 6.23%.
- Does ABBV or QCOM pay a bigger dividend?
- ABBV yields 2.68% and QCOM yields 2.05% based on trailing dividends and the latest price.
- Is ABBV or QCOM more profitable?
- QCOM runs the higher net margin — ABBV at 9.81% versus QCOM at 21.01%.
- How have ABBV and QCOM total returns compared?
- Over the past 10 years, ABBV delivered 19.76% and QCOM delivered 14.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioQUALCOMM P/E ratioAbbVie dividend yieldQUALCOMM dividend yieldAbbVie ROEQUALCOMM ROEAbbVie operating marginQUALCOMM operating marginAbbVie revenue growthQUALCOMM revenue growthAbbVie free cash flowQUALCOMM free cash flow
AbbVie & QUALCOMM appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.